Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Israel - Inggeris - Ministry of Health

unipharm ltd, israel - cilazapril; hydrochlorothiazide - tablets - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - chloramphenicol, quantity: 10 mg/g - eye ointment - excipient ingredients: wool fat; liquid paraffin; white soft paraffin - indications as at 29 january 2001: for the treatment of bacterial conjunctivitis and other superficial ocular infections caused by chloramphenicol-sensitive organisms.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 10.844mg equivalent to atorvastatin 10 mg;   - film coated tablet - 10 mg - active: atorvastatin calcium trihydrate 10.844mg equivalent to atorvastatin 10 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 21.688mg equivalent to atorvastatin 20 mg;   - film coated tablet - 20 mg - active: atorvastatin calcium trihydrate 21.688mg equivalent to atorvastatin 20 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 43.376mg equivalent to atorvastatin 40 mg;   - film coated tablet - 40 mg - active: atorvastatin calcium trihydrate 43.376mg equivalent to atorvastatin 40 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - atorvastatin calcium trihydrate 86.751mg equivalent to atorvastatin 80 mg;   - film coated tablet - 80 mg - active: atorvastatin calcium trihydrate 86.751mg equivalent to atorvastatin 80 mg   excipient: arginine colloidal silicon dioxide croscarmellose sodium hyprolose lactose magnesium stearate microcrystalline cellulose opadry white 85f18378 opadry white oy-b-28920 amb sodium carbonate - lorstat is indicated as an adjunct to diet to reduce elevated total-c, ldl-c and tg levels in patients with primary hypercholesterolaemia or mixed dyslipidaemia where the primary abnormality is either elevated cholesterol or triglycerides when response to diet and other non-pharmacological measures is inadequate. lorstat is also indicated to reduce total-c and ldl-c in patients with heterozygous and homozygous familial hypercholesterolaemia.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - atorvastatin calcium trihydrate, quantity: 21.688 mg (equivalent: atorvastatin, qty 20 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; sodium carbonate; hyprolose; lactose; arginine; croscarmellose sodium; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - lorstat is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.,prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.,lorstat is indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke.,these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.